Arcellx (ACLX) Enterprise Value (2021 - 2025)
Arcellx (ACLX) recorded quarterly Enterprise Value of -$450.3 million in Q4 2025, up 2.39% quarter-over-quarter from -$461.4 million in Q3 2025, and up 23.33% on a YoY basis from -$365.1 million in Q4 2024.
Arcellx (ACLX) Enterprise Value (2021 - 2025) Analysis & Trends
Arcellx's Enterprise Value history runs 5 years deep, the most recent figure standing at -$450.3 million for Q4 2025.
- In Q4 2025, Enterprise Value rose 23.33% year-over-year to -$450.3 million; the TTM figure through Dec 2025 stood at -$450.3 million (up 23.33% YoY), while the FY2025 annual figure was -$450.3 million, up 23.33% from the prior year.
- Enterprise Value was -$450.3 million for Q4 2025 at Arcellx, up from -$461.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$64.2 million in Q4 2022 to a low of -$702.0 million in Q4 2023.
- Historically, Enterprise Value has averaged -$382.1 million across 5 years, with a median of -$451.7 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value surged 38.65% in 2022, then tumbled 993.84% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$104.6 million in 2021, then soared by 38.65% to -$64.2 million in 2022, then sank by 993.84% to -$702.0 million in 2023, then increased by 16.33% to -$587.4 million in 2024, then gained by 23.33% to -$450.3 million in 2025.
- The last three Enterprise Value figures came in at -$450.3 million (Q4 2025), -$461.4 million (Q3 2025), and -$453.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -584.73 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -450.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -450.33 Mn |
| Sep 30, 2025 | -461.38 Mn |
| Jun 30, 2025 | -453.10 Mn |
| Mar 31, 2025 | -543.27 Mn |
| Dec 31, 2024 | -587.38 Mn |
| Sep 30, 2024 | -574.25 Mn |
| Jun 30, 2024 | -516.69 Mn |
| Mar 31, 2024 | -573.92 Mn |
| Dec 31, 2023 | -702.02 Mn |
| Sep 30, 2023 | -439.72 Mn |
| Jun 30, 2023 | -506.48 Mn |
| Mar 31, 2023 | -533.59 Mn |
| Dec 31, 2022 | -64.18 Mn |
| Sep 30, 2022 | -280.78 Mn |
| Jun 30, 2022 | -306.99 Mn |
| Mar 31, 2022 | -210.93 Mn |
| Dec 31, 2021 | -104.62 Mn |
| Sep 30, 2021 | -70.03 Mn |
| Jun 30, 2021 | -143.79 Mn |
| Mar 31, 2021 | -117.65 Mn |